Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy: Results of an Updated Analysis. FE [Internet]. 2024 Dec. 17 [cited 2025 Oct. 29];25(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1568